Concepts (289)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cannabis | 23 | 2025 | 85 | 11.180 |
Why?
|
| Smoking | 19 | 2022 | 429 | 4.450 |
Why?
|
| Marijuana Use | 8 | 2024 | 38 | 4.300 |
Why?
|
| Hallucinogens | 6 | 2022 | 23 | 3.790 |
Why?
|
| Alcohol Drinking | 14 | 2025 | 356 | 3.760 |
Why?
|
| Pregnancy | 30 | 2025 | 1463 | 3.550 |
Why?
|
| Electronic Nicotine Delivery Systems | 10 | 2022 | 29 | 3.430 |
Why?
|
| Prenatal Care | 11 | 2023 | 127 | 3.410 |
Why?
|
| Substance-Related Disorders | 12 | 2025 | 425 | 3.210 |
Why?
|
| Pregnant Women | 7 | 2022 | 46 | 3.070 |
Why?
|
| Female | 79 | 2025 | 12396 | 3.030 |
Why?
|
| Humans | 94 | 2025 | 17314 | 2.900 |
Why?
|
| Marijuana Smoking | 6 | 2024 | 52 | 2.850 |
Why?
|
| Pregnancy Complications | 5 | 2025 | 197 | 2.540 |
Why?
|
| Adult | 57 | 2025 | 7500 | 2.520 |
Why?
|
| Intimate Partner Violence | 4 | 2023 | 11 | 2.450 |
Why?
|
| Vaping | 7 | 2024 | 19 | 2.400 |
Why?
|
| Marijuana Abuse | 5 | 2021 | 43 | 2.120 |
Why?
|
| California | 25 | 2025 | 2311 | 2.040 |
Why?
|
| Nicotine | 5 | 2025 | 27 | 2.030 |
Why?
|
| Mental Disorders | 11 | 2020 | 274 | 1.920 |
Why?
|
| Smoking Cessation | 12 | 2020 | 154 | 1.820 |
Why?
|
| Legislation, Drug | 3 | 2024 | 10 | 1.760 |
Why?
|
| Self Report | 9 | 2022 | 257 | 1.680 |
Why?
|
| Delivery of Health Care, Integrated | 7 | 2021 | 535 | 1.480 |
Why?
|
| Young Adult | 24 | 2024 | 2465 | 1.420 |
Why?
|
| Tobacco Products | 4 | 2021 | 14 | 1.340 |
Why?
|
| Public Health | 4 | 2022 | 83 | 1.290 |
Why?
|
| Male | 45 | 2025 | 9804 | 1.280 |
Why?
|
| Adolescent | 22 | 2024 | 3538 | 1.270 |
Why?
|
| Cross-Sectional Studies | 15 | 2024 | 1280 | 1.240 |
Why?
|
| Prevalence | 11 | 2025 | 840 | 1.200 |
Why?
|
| Tobacco Use Disorder | 4 | 2017 | 36 | 1.180 |
Why?
|
| Smoke-Free Policy | 4 | 2017 | 6 | 1.140 |
Why?
|
| Middle Aged | 33 | 2024 | 7836 | 1.100 |
Why?
|
| Crime Victims | 3 | 2018 | 25 | 1.070 |
Why?
|
| Breast Feeding | 4 | 2021 | 113 | 1.040 |
Why?
|
| Life Change Events | 3 | 2018 | 31 | 1.030 |
Why?
|
| Alcoholism | 6 | 2017 | 337 | 1.030 |
Why?
|
| Counseling | 4 | 2020 | 174 | 0.980 |
Why?
|
| Resilience, Psychological | 1 | 2025 | 11 | 0.950 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2020 | 381 | 0.950 |
Why?
|
| Delivery of Health Care | 8 | 2022 | 390 | 0.930 |
Why?
|
| Mental Health | 3 | 2022 | 169 | 0.930 |
Why?
|
| United States | 20 | 2022 | 3866 | 0.930 |
Why?
|
| Hearing Loss | 1 | 2025 | 18 | 0.910 |
Why?
|
| Medical Marijuana | 2 | 2021 | 23 | 0.860 |
Why?
|
| Tobacco Smoking | 2 | 2021 | 19 | 0.830 |
Why?
|
| Anxiety Disorders | 3 | 2022 | 92 | 0.820 |
Why?
|
| Retrospective Studies | 11 | 2025 | 2415 | 0.820 |
Why?
|
| Risk Factors | 13 | 2025 | 3258 | 0.820 |
Why?
|
| Methamphetamine | 1 | 2022 | 3 | 0.790 |
Why?
|
| Qualitative Research | 1 | 2024 | 260 | 0.790 |
Why?
|
| Cocaine | 1 | 2022 | 7 | 0.790 |
Why?
|
| HIV Infections | 4 | 2021 | 712 | 0.790 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2025 | 168 | 0.780 |
Why?
|
| Electronic Health Records | 6 | 2024 | 704 | 0.780 |
Why?
|
| Surveys and Questionnaires | 12 | 2022 | 1282 | 0.750 |
Why?
|
| Patient Protection and Affordable Care Act | 6 | 2020 | 42 | 0.750 |
Why?
|
| Child | 10 | 2022 | 2403 | 0.740 |
Why?
|
| Adult Survivors of Child Abuse | 2 | 2012 | 6 | 0.720 |
Why?
|
| Alcohol-Related Disorders | 2 | 2012 | 48 | 0.710 |
Why?
|
| Documentation | 2 | 2020 | 40 | 0.710 |
Why?
|
| Mass Screening | 4 | 2020 | 672 | 0.690 |
Why?
|
| Anxiety | 3 | 2022 | 154 | 0.680 |
Why?
|
| Insurance Coverage | 3 | 2020 | 104 | 0.680 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2022 | 151 | 0.680 |
Why?
|
| Stress, Psychological | 5 | 2022 | 134 | 0.660 |
Why?
|
| Opioid-Related Disorders | 3 | 2017 | 173 | 0.660 |
Why?
|
| Twins, Monozygotic | 3 | 2015 | 11 | 0.660 |
Why?
|
| Spouse Abuse | 2 | 2017 | 8 | 0.660 |
Why?
|
| Consultants | 1 | 2019 | 1 | 0.650 |
Why?
|
| Postnatal Care | 1 | 2019 | 20 | 0.640 |
Why?
|
| Smoking Prevention | 2 | 2017 | 35 | 0.640 |
Why?
|
| Drug Administration Routes | 1 | 2019 | 5 | 0.640 |
Why?
|
| Health Policy | 2 | 2018 | 109 | 0.630 |
Why?
|
| Pandemics | 6 | 2023 | 287 | 0.610 |
Why?
|
| Patient Participation | 2 | 2020 | 119 | 0.610 |
Why?
|
| Mothers | 1 | 2019 | 103 | 0.600 |
Why?
|
| Aged | 14 | 2024 | 6084 | 0.600 |
Why?
|
| Longitudinal Studies | 11 | 2020 | 674 | 0.590 |
Why?
|
| Health Personnel | 1 | 2020 | 126 | 0.590 |
Why?
|
| Cannabinoid Receptor Agonists | 3 | 2022 | 8 | 0.590 |
Why?
|
| Sex Offenses | 1 | 2018 | 9 | 0.590 |
Why?
|
| Depression | 4 | 2022 | 486 | 0.580 |
Why?
|
| Depressive Disorder | 1 | 2020 | 185 | 0.570 |
Why?
|
| Adult Survivors of Child Adverse Events | 1 | 2018 | 4 | 0.570 |
Why?
|
| Twins, Dizygotic | 2 | 2015 | 7 | 0.550 |
Why?
|
| Tobacco Use Cessation | 1 | 2017 | 18 | 0.530 |
Why?
|
| Medicaid | 2 | 2018 | 189 | 0.520 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2014 | 68 | 0.510 |
Why?
|
| Health Communication | 1 | 2016 | 16 | 0.500 |
Why?
|
| Professional-Patient Relations | 1 | 2016 | 48 | 0.490 |
Why?
|
| Guidelines as Topic | 1 | 2016 | 41 | 0.490 |
Why?
|
| Socioeconomic Factors | 5 | 2024 | 605 | 0.480 |
Why?
|
| Social Environment | 3 | 2015 | 85 | 0.470 |
Why?
|
| Underage Drinking | 1 | 2015 | 6 | 0.470 |
Why?
|
| Social Behavior | 1 | 2015 | 21 | 0.470 |
Why?
|
| Depressive Disorder, Major | 3 | 2013 | 100 | 0.460 |
Why?
|
| Attitude | 1 | 2015 | 28 | 0.460 |
Why?
|
| Menthol | 1 | 2014 | 1 | 0.450 |
Why?
|
| Motivation | 4 | 2015 | 115 | 0.450 |
Why?
|
| Prisons | 1 | 2015 | 29 | 0.450 |
Why?
|
| Analgesics, Opioid | 1 | 2017 | 245 | 0.440 |
Why?
|
| Diseases in Twins | 3 | 2013 | 15 | 0.440 |
Why?
|
| Analgesics | 3 | 2022 | 27 | 0.430 |
Why?
|
| Adaptation, Psychological | 2 | 2022 | 78 | 0.420 |
Why?
|
| Cannabinoids | 2 | 2024 | 8 | 0.410 |
Why?
|
| Taxes | 1 | 2013 | 23 | 0.410 |
Why?
|
| Health Resources | 1 | 2013 | 34 | 0.410 |
Why?
|
| Health Surveys | 1 | 2013 | 245 | 0.390 |
Why?
|
| Stress, Physiological | 1 | 2012 | 3 | 0.390 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 268 | 0.380 |
Why?
|
| San Francisco | 4 | 2015 | 59 | 0.360 |
Why?
|
| Vitamins | 2 | 2022 | 60 | 0.360 |
Why?
|
| Ethanol | 2 | 2022 | 21 | 0.360 |
Why?
|
| Logistic Models | 5 | 2021 | 879 | 0.350 |
Why?
|
| Postpartum Period | 2 | 2021 | 79 | 0.340 |
Why?
|
| Attitude of Health Personnel | 2 | 2024 | 197 | 0.340 |
Why?
|
| Lactation | 2 | 2021 | 34 | 0.330 |
Why?
|
| Infant, Newborn | 2 | 2025 | 805 | 0.330 |
Why?
|
| Sex Factors | 4 | 2017 | 603 | 0.330 |
Why?
|
| Tobacco Use | 2 | 2020 | 14 | 0.320 |
Why?
|
| Child Abuse | 1 | 2010 | 43 | 0.310 |
Why?
|
| Affect | 1 | 2009 | 21 | 0.310 |
Why?
|
| Women's Health | 2 | 2022 | 197 | 0.310 |
Why?
|
| Reproductive History | 1 | 2017 | 17 | 0.280 |
Why?
|
| Breast Diseases | 1 | 2017 | 18 | 0.280 |
Why?
|
| Calcinosis | 1 | 2017 | 35 | 0.280 |
Why?
|
| Breast | 1 | 2017 | 84 | 0.270 |
Why?
|
| Metabolic Syndrome | 1 | 2007 | 65 | 0.270 |
Why?
|
| Sexual Partners | 2 | 2019 | 38 | 0.260 |
Why?
|
| Postmenopause | 1 | 2017 | 248 | 0.260 |
Why?
|
| Age of Onset | 4 | 2015 | 70 | 0.250 |
Why?
|
| Mammography | 1 | 2017 | 168 | 0.250 |
Why?
|
| Vomiting | 1 | 2024 | 15 | 0.220 |
Why?
|
| Social Norms | 1 | 2024 | 2 | 0.220 |
Why?
|
| Age Factors | 4 | 2014 | 878 | 0.210 |
Why?
|
| Health Services Accessibility | 4 | 2020 | 271 | 0.210 |
Why?
|
| Educational Status | 3 | 2020 | 177 | 0.210 |
Why?
|
| Adolescent Behavior | 1 | 2024 | 121 | 0.200 |
Why?
|
| Prospective Studies | 3 | 2022 | 1226 | 0.200 |
Why?
|
| Industry | 1 | 2022 | 1 | 0.190 |
Why?
|
| Drug and Narcotic Control | 1 | 2022 | 5 | 0.190 |
Why?
|
| Virginia | 2 | 2012 | 5 | 0.190 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 532 | 0.190 |
Why?
|
| Comorbidity | 4 | 2020 | 560 | 0.190 |
Why?
|
| Motivational Interviewing | 1 | 2022 | 34 | 0.190 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2022 | 57 | 0.190 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2021 | 22 | 0.180 |
Why?
|
| Preconception Care | 1 | 2022 | 40 | 0.180 |
Why?
|
| Cannabidiol | 1 | 2021 | 1 | 0.180 |
Why?
|
| Pilot Projects | 2 | 2019 | 211 | 0.180 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2024 | 367 | 0.180 |
Why?
|
| Infant | 1 | 2025 | 1161 | 0.180 |
Why?
|
| Social Media | 1 | 2021 | 11 | 0.180 |
Why?
|
| Pregnancy, Unwanted | 1 | 2020 | 7 | 0.170 |
Why?
|
| Family | 2 | 2019 | 106 | 0.170 |
Why?
|
| Psychotic Disorders | 1 | 2021 | 49 | 0.170 |
Why?
|
| Workload | 1 | 2020 | 25 | 0.170 |
Why?
|
| Intention | 1 | 2020 | 30 | 0.170 |
Why?
|
| Self Medication | 1 | 2020 | 5 | 0.160 |
Why?
|
| Psychological Trauma | 1 | 2020 | 6 | 0.160 |
Why?
|
| International Agencies | 1 | 2019 | 1 | 0.160 |
Why?
|
| Obstetrics | 1 | 2020 | 20 | 0.160 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 50 | 0.160 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 57 | 0.160 |
Why?
|
| Skin Cream | 1 | 2019 | 3 | 0.160 |
Why?
|
| Mentally Ill Persons | 2 | 2016 | 3 | 0.160 |
Why?
|
| Plants, Edible | 1 | 2019 | 6 | 0.160 |
Why?
|
| Patient-Centered Care | 1 | 2021 | 186 | 0.160 |
Why?
|
| Cohort Studies | 3 | 2024 | 2514 | 0.160 |
Why?
|
| Palliative Care | 1 | 2020 | 52 | 0.160 |
Why?
|
| Suicide | 1 | 2020 | 116 | 0.150 |
Why?
|
| Regression Analysis | 2 | 2017 | 270 | 0.150 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 1925 | 0.150 |
Why?
|
| Meaningful Use | 1 | 2018 | 5 | 0.150 |
Why?
|
| Emergency Service, Hospital | 2 | 2024 | 384 | 0.150 |
Why?
|
| Physician-Patient Relations | 1 | 2020 | 163 | 0.150 |
Why?
|
| Referral and Consultation | 1 | 2020 | 157 | 0.150 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 535 | 0.140 |
Why?
|
| Substance Abuse Detection | 1 | 2017 | 18 | 0.140 |
Why?
|
| Primary Health Care | 2 | 2021 | 726 | 0.140 |
Why?
|
| Feasibility Studies | 1 | 2018 | 108 | 0.140 |
Why?
|
| Patient Admission | 1 | 2017 | 69 | 0.130 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2014 | 33 | 0.130 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 342 | 0.130 |
Why?
|
| Natural Language Processing | 1 | 2017 | 60 | 0.130 |
Why?
|
| Health Services Needs and Demand | 1 | 2017 | 87 | 0.130 |
Why?
|
| Buprenorphine | 1 | 2017 | 48 | 0.130 |
Why?
|
| Healthcare Disparities | 1 | 2018 | 202 | 0.130 |
Why?
|
| Quality of Life | 1 | 2019 | 499 | 0.120 |
Why?
|
| Cooking | 1 | 2015 | 17 | 0.120 |
Why?
|
| Nutritional Sciences | 1 | 2015 | 9 | 0.120 |
Why?
|
| Meals | 1 | 2015 | 7 | 0.120 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 452 | 0.120 |
Why?
|
| Twins | 2 | 2012 | 11 | 0.120 |
Why?
|
| Time Factors | 1 | 2018 | 1039 | 0.120 |
Why?
|
| Nonlinear Dynamics | 1 | 2015 | 7 | 0.120 |
Why?
|
| Multilevel Analysis | 1 | 2015 | 11 | 0.120 |
Why?
|
| Hypertension | 1 | 2019 | 469 | 0.120 |
Why?
|
| Gender Identity | 1 | 2015 | 33 | 0.120 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2015 | 12 | 0.120 |
Why?
|
| Residence Characteristics | 2 | 2014 | 253 | 0.120 |
Why?
|
| Environment | 1 | 2015 | 50 | 0.110 |
Why?
|
| Cancer Survivors | 1 | 2016 | 101 | 0.110 |
Why?
|
| Decision Making | 1 | 2016 | 171 | 0.110 |
Why?
|
| Feeding Behavior | 1 | 2015 | 163 | 0.110 |
Why?
|
| Severity of Illness Index | 5 | 2015 | 437 | 0.110 |
Why?
|
| Linear Models | 1 | 2015 | 206 | 0.110 |
Why?
|
| Sex | 1 | 2014 | 2 | 0.110 |
Why?
|
| Quality Improvement | 1 | 2016 | 188 | 0.110 |
Why?
|
| Restaurants | 1 | 2014 | 17 | 0.110 |
Why?
|
| Internet | 1 | 2015 | 212 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 664 | 0.110 |
Why?
|
| Vocabulary | 1 | 2013 | 1 | 0.110 |
Why?
|
| Minority Groups | 1 | 2014 | 104 | 0.110 |
Why?
|
| Memory | 1 | 2013 | 12 | 0.110 |
Why?
|
| Attention | 1 | 2013 | 11 | 0.110 |
Why?
|
| Cotinine | 1 | 2013 | 7 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2016 | 302 | 0.100 |
Why?
|
| Interpersonal Relations | 1 | 2013 | 41 | 0.100 |
Why?
|
| Risk-Taking | 1 | 2014 | 106 | 0.100 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2010 | 104 | 0.100 |
Why?
|
| Nicotinic Agonists | 1 | 2012 | 15 | 0.100 |
Why?
|
| Quinoxalines | 1 | 2012 | 12 | 0.100 |
Why?
|
| Benzazepines | 1 | 2012 | 24 | 0.100 |
Why?
|
| Environmental Exposure | 1 | 2013 | 121 | 0.100 |
Why?
|
| Sex Characteristics | 1 | 2012 | 66 | 0.090 |
Why?
|
| Twin Studies as Topic | 1 | 2011 | 3 | 0.090 |
Why?
|
| Genetics, Behavioral | 1 | 2011 | 1 | 0.090 |
Why?
|
| Schizotypal Personality Disorder | 1 | 2011 | 2 | 0.090 |
Why?
|
| Genotype | 1 | 2011 | 223 | 0.090 |
Why?
|
| Early Detection of Cancer | 1 | 2016 | 529 | 0.090 |
Why?
|
| Antisocial Personality Disorder | 1 | 2010 | 2 | 0.080 |
Why?
|
| Child Abuse, Sexual | 1 | 2010 | 13 | 0.080 |
Why?
|
| Registries | 1 | 2012 | 460 | 0.080 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2009 | 25 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 372 | 0.080 |
Why?
|
| Odds Ratio | 1 | 2010 | 640 | 0.070 |
Why?
|
| Arteries | 1 | 2017 | 8 | 0.070 |
Why?
|
| Sweden | 1 | 2007 | 19 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 298 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2007 | 202 | 0.070 |
Why?
|
| Coronary Artery Disease | 1 | 2007 | 112 | 0.060 |
Why?
|
| Health Behavior | 2 | 2018 | 346 | 0.050 |
Why?
|
| Income | 2 | 2013 | 86 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2022 | 226 | 0.050 |
Why?
|
| Florida | 1 | 2021 | 6 | 0.040 |
Why?
|
| Infection Control | 1 | 2020 | 8 | 0.040 |
Why?
|
| Prognosis | 1 | 2022 | 603 | 0.040 |
Why?
|
| Vulnerable Populations | 1 | 2020 | 34 | 0.040 |
Why?
|
| Psychometrics | 1 | 2020 | 119 | 0.040 |
Why?
|
| Continuity of Patient Care | 1 | 2021 | 103 | 0.040 |
Why?
|
| Focus Groups | 1 | 2020 | 143 | 0.040 |
Why?
|
| Pain | 1 | 2020 | 75 | 0.040 |
Why?
|
| Behavior Therapy | 1 | 2020 | 126 | 0.040 |
Why?
|
| Alcoholic Intoxication | 1 | 2017 | 6 | 0.030 |
Why?
|
| Binge Drinking | 1 | 2017 | 8 | 0.030 |
Why?
|
| Opiate Substitution Treatment | 1 | 2017 | 45 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2020 | 1076 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2015 | 32 | 0.030 |
Why?
|
| Transdermal Patch | 1 | 2015 | 1 | 0.030 |
Why?
|
| Neoplasms | 1 | 2020 | 446 | 0.030 |
Why?
|
| Adolescent Health Services | 1 | 2015 | 40 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1098 | 0.030 |
Why?
|
| Set (Psychology) | 1 | 2013 | 1 | 0.030 |
Why?
|
| Automobiles | 1 | 2013 | 2 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2013 | 43 | 0.030 |
Why?
|
| Arousal | 1 | 2013 | 4 | 0.030 |
Why?
|
| Mental Recall | 1 | 2013 | 29 | 0.030 |
Why?
|
| Housing | 1 | 2013 | 37 | 0.030 |
Why?
|
| Mental Health Services | 1 | 2015 | 155 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2013 | 71 | 0.030 |
Why?
|
| Varenicline | 1 | 2012 | 12 | 0.030 |
Why?
|
| Poverty | 1 | 2013 | 168 | 0.020 |
Why?
|
| Population | 1 | 2011 | 3 | 0.020 |
Why?
|
| Marital Status | 1 | 2011 | 20 | 0.020 |
Why?
|
| Triplets | 1 | 2011 | 2 | 0.020 |
Why?
|
| Personality | 1 | 2011 | 9 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2011 | 23 | 0.020 |
Why?
|
| Los Angeles | 1 | 2011 | 139 | 0.020 |
Why?
|
| Phenotype | 1 | 2011 | 149 | 0.020 |
Why?
|
| Northern Ireland | 1 | 2010 | 1 | 0.020 |
Why?
|
| Personality Inventory | 1 | 2010 | 12 | 0.020 |
Why?
|
| Siblings | 1 | 2010 | 12 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2010 | 43 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2010 | 24 | 0.020 |
Why?
|
| Ethnic Groups | 1 | 2011 | 451 | 0.020 |
Why?
|
Concepts
(289)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(30)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->